The PharmaLedger project is constituting the External Expert Advisory Board (EEAB) with the aim to provide expert advice to the project.
This Board is made up of members from different stakeholders, diverse domain-specific research groups and various industry experts.
The EEAB will provide feedback on key project’s documents through virtual and selected face-to-face- meetings. These meetings will be conducted with members of the PharmaLedger Consortium, workshops, events or demonstrations for market outreach reasons. The feedback provided by the EEAB members is expected to strengthen the Consortium’s knowledge capacity and assist on the appropriateness of consulted issues.
Currently, several members are still under internal confirmation process.